France· FR:63681430
TIADILON 100 mg, gélule
A tidiacic arginin product containing tidiacic arginine, registered in France by CRINEX.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TIDIACIC ARGININE
- Manufacturer
- CRINEX
- Country
- France (FR)
- ATC code
- A05BA07
- ATC class
- Tidiacic arginin
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400931584285plaquette(s) thermoformée(s) PVC-Aluminium de 20 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aceb79b9-3195-4424-b2fa-64221766c118 GET /v1/drugs/aceb79b9-3195-4424-b2fa-64221766c118?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63681430",
"date_amm": "1991-03-25",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TIDIACIC ARGININE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tidiacic arginin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.